Catalent | CTLT - Cost Of Sales


Catalent reported $842M in Cost of Sales for its fiscal quarter ending in September of 2024.



Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Bruker USD 528M 46.9M Dec/2025
Centene USD 47.59B 831M Dec/2025
Charles River Laboratories USD 722.27M 28.81M Dec/2025
Cigna USD 63.37B 1.93B Sep/2025
Danaher USD 2.87B 342M Dec/2025
Dentsply International USD 518M 55M Dec/2025
Elevance Health USD 38.07B 75M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Glaxosmithkline GBP 3.01B 853.01M Sep/2025
Hologic USD 463.7M 5.1M Dec/2025
Humana USD 26.54B 1.15B Mar/2025
Illumina USD 400M 49M Dec/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
J&J USD 7.97B 689M Dec/2025
Laboratory Of America USD 2.6B 56.8M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
McKesson USD 102.47B 2.86B Dec/2025
Merck EUR 2.29B 183M Dec/2025
Merck USD 3.32B 531M Dec/2025
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Quest Diagnostics USD 1.93B 27M Dec/2025
Repligen USD 94.08M 5.79M Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Supernus Pharmaceuticals USD 47.53M 4.24M Dec/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
UnitedHealth USD 92.52B 920M Sep/2025
Veradigm USD 68.49M 2.93M Sep/2022
Waters USD 374.94M 47.13M Dec/2025
West Pharmaceutical Services USD 501.1M 9.2M Dec/2025